By NZPA
|
Friday 21st February 2003 |
Text too small? |
The now-Australasian company said its interim profit dropped 2 percent or just over $200,000 to $9.4 million compared to the second half of 2001.
A fully imputed dividend of 9.5c per share was declared.
Nuplex said it remained on track to post a record year end net surplus which would be more than 50 percent higher than last year's full year result of $12.6 million.
This was in spite of offshore earnings being significantly impacted by the strong New Zealand dollar relative to Australian and US currencies, the company said.
Shares in Nuplex fell 2c to $3.51 at midday (NZ time).
Total operating revenue was higher at $318.4 million compared with $214.6 million in the corresponding period the year before.
But its operating surplus was hit by higher tax and a decision to writedown a further $2.9 million on the carrying value of poorly Australian subsidiary, Medihold.
Earnings per share were 15.7c compared with 16.5c the year before.
Another writedown on underperforming subsidiary Medihold has slightly lowered the December half year net profit of listed chemical company Nuplex.
The now-Australasian company said its interim profit dropped 2 percent or just over $200,000 to $9.4 million compared to the second half of 2001.
A fully imputed dividend of 9.5c per share was declared.
Nuplex said it remained on track to post a record year end net surplus which would be more than 50 percent higher than last year's full year result of $12.6 million.
This was in spite of offshore earnings being significantly impacted by the strong New Zealand dollar relative to Australian and US currencies, the company said.
Shares in Nuplex fell 2c to $3.51 at midday (NZ time).
Total operating revenue was higher at $318.4 million compared with $214.6 million in the corresponding period the year before.
But its operating surplus was hit by higher tax and a decision to writedown a further $2.9 million on the carrying value of poorly Australian subsidiary, Medihold.
Earnings per share were 15.7c compared with 16.5c the year before.
No comments yet
Nuplex targets half billion dollar Asian sales within five years
Nuplex FY profit drops 31 percent on weak ANZ, EMEA markets, writedowns
Nuplex cuts FY guidance again as Australian manufacturing splutters; stock drops
Nuplex 1H profit misses forecasts; annual guidance cut on strong kiwi, weak trading conditions
Nuplex looks at imputing future dividends, flags increased earnings
Nuplex plans restructuring in Australia, NZ to cut 2013 profit
Nuplex FY profit falls, guidance met
Nuplex raises US$105M in US private placement
Nuplex sees full-year earnings at bottom of range
Nuplex 1H profit drops 23% on Australasian weakness
